Skip to content
CLADsolve

Paper

Spectrum of chronic lung allograft dysfunction pathology in human lung transplantation.

Evidence level: human explant histology study (20 CLAD patients, 13 controls); abstract-only

A Toronto histology study of explanted lungs from 20 patients retransplanted for CLAD, reporting a wide overlap between BOS and RAS pathology.

As of . Primary source: Publisher record via DOI.

Summary

According to the abstract, paraffin-embedded explant samples from 3 lobes of 20 consecutive patients undergoing a second lung transplant for CLAD were compared with 13 control samples from lobectomies or donor lungs, using blinded semi-quantitative grading of airway fibrosis, parenchymal and pleural fibrosis, and epithelial and vascular abnormalities. CLAD samples scored higher than controls on all airway- and lung-related parameters. The abstract reports a notable overlap in scores between BOS and RAS, with parenchymal and vascular fibrosis scores significantly higher in RAS (p = 0.003 for both). Immunofluorescence showed a trend toward fewer club cells in CLAD and a higher frequency of apoptotic club cells in BOS samples (p = 0.01). The authors conclude that CLAD is a spectrum of airway, parenchymal and pleural fibrosis with epithelial, vascular and inflammatory changes, and that their grading score may be useful for future histologic assessment. The authors include Tereza Martinu and Stephen Juvet.

Details

doi
10.1016/j.healun.2024.04.002
pmid
38663465
authors
Renaud-Picard B, Berra G, Hwang D, Huszti E, Miyamoto E, Berry GJ, Pal P, Juvet S, Keshavjee S, Martinu T
journal
The Journal of Heart and Lung Transplantation
year
2024
volume
43
issue
10
pages
1701-1715

Sources and links

Related

Links from this record

Linked from (derived)

Known gaps in this record

  • full text not read (abstract only)
  • funding statement and grant numbers
  • full author affiliations (only the PubMed affiliation text was checked for named centres)

Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.